Clinical Trial Update: Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 SPORE trial evaluating cetuximab plus radiation therapy in patients with laryngeal cancer who responded to one cycle of chemoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngeal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Cancer of Larynx | Phase 2 | Status: TERMINATED | Results posted: 2014-06-16